Newcastle disease virus, rituximab, and doxorubicin combination as anti-hematological malignancy therapy
Ahmed Majeed Al-Shammari,1 Huda Rameez,2 Maha F Al-Taee2 1Department of Experimental Therapy, Iraqi Center for Cancer and Medical Genetic Research, Mustansiriyah University, 2Department of Biotechnology, College of Science, Baghdad University, Baghdad, IraqAbstract: Hematological malignancies are im...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2016-04-01
|
| Series: | Oncolytic Virotherapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/newcastle-disease-virus-rituximab-and-doxorubicin-combination-as-anti--peer-reviewed-article-OV |